Böcker i Updates in Clinical Dermatology-serien

It is caused by a variety of compounds, such as foods, preservatives, fragrances, plant and animal products, metals, and rubber latex and the mechanism by which these provoke an immediate urticarial rash at the area of contact can be divided into two categories: non-immunological contact urticaria and immunological (allergic) contact urticaria.

Diagnosis and management of pigmentary skin disorders has become an important area in dermatology as the demand for treatment of these conditions has increased exponentially, particularly with skin of color.

Biologic therapy is a treatment that strives to modulate a patient's immune system to fight a given disease. In psoriasis, a skin disorder that is partly caused by a dysregulated immune system resulting in well-demarcated red areas of the skin with white scales, biologic therapy has the potential to vastly improve upon patient outcomes by minimizing the symptoms of this disease while maximizing the safety profile of the therapy.   This book offers an up-to-date and comprehensive review on biologic therapy for the treatment of psoriasis. With over 10 FDA approved biologic agents for psoriasis (with more in the pipeline), confusion exists among providers regarding which agent is best for a particular patient. Chapters cover all FDA approved psoriasis biologic agents (including pipeline agents) for use in pediatric, adult, and geriatric patients. This book is unique in that it will not only cover cutting edge treatment principles based on the latest research, it will also be one of the most comprehensive reviews of psoriasis biologics in the COVID-19 era.   Biologic Therapy for Psoriasis is a must-have resource for board certified dermatologists and rheumatologists, dermatology and rheumatology residents and fellows, dermatology physician assistants, nurse practitioners and medical students. The ultimate goal of this book is to improve patient care by making the busy practicing dermatology provider more adept with these particular therapies.

Cutaneous adverse drug reactions are common and range from the benign to those which are life-threatening. The clinical presentation of these dermatoses is varied and many may mimic common skin conditions. Consequently, diagnosis in drug-induced skin disease is challenging and the treatment considerations are complex.     This book aims to bridge the divide between dermatology and allergy by providing a comprehensive review on the pathomechanisms and clinical features of cutaneous adverse drug reactions. Broken up into three distinct sections: General Considerations, Reaction Patterns, and Special Drug Categories, these chapters cover the common and rare adverse skin reactions and provide information on recent advances - particularly immunopathology and pharmacogenetics - as well as highlighting new adverse drug signals and novel therapies. Drug Eruptions is a must-have resource for dermatologists, allergists, internal physicians and general practitioners.

This handbook offers a comprehensive overview of the variety of skin issues that can arise while at work. It is meant to guide dermatologists, allergists, and industrial physicians in the successful diagnostic and management of the patients suffering from occupational skin dermatoses. It provides a look at the current modes of treatment available to practicing physicians while also offering updates on the most recent changes and advances for easy integration into practice. With an depth look at some of the more common diseases, like various urticaria and eczema as well as examining specific work places prone to exposure, this book will provide a quick and easy-to-use reference. Chapters contain patient photos and offer a multidisciplinary approach with special chapters on medical legal implications as well as exploring the minimum standards on prevention, diagnosis, and treatment as viewed worldwide. Handbook of Occupational Dermatoses is a must-have resource for dermatologists, allergists, and primary care physicians that deal with these skin issues everyday.

This book offers a comprehensive and the foundational structure for all healthcare professionals developing, practicing, and performing research in teledermatology. The chapters of this book examines the field of teledermatology and will include: platforms and practice models, the impact of COVID-19, the telehealth and mobile teledermatology industry, the effect on healthcare accessibility, equality, specialty referrals and no-show rates, cost effectiveness, implementation, regulations and reimbursement, practice guidelines, outcomes for skin lesions, inflammatory dermatoses, inpatient consultations and pediatrics, research utilization, education, image quality and artificial intelligence, global and international efforts as well as patient and physician satisfaction. Chapters are authored by leaders in the field of dermatology and teledermatology. The goal is for the reader to become knowledgeable and proficient within field of teledermatology to increase patient access, manageskin disease and develop beneficial outcomes via electronic consultations.Teledermatology: A Comprehensive Overview is a must-have resource for dermatologists, dermatology academic and hospital leadership, hospital administrators, and telehealth programs.

Since the first cases of an acute respiratory illness were reported, the pathogen SARS-coV-2 (severe acute respiratory syndrome coronavirus 2) and its disease, COVID-19 have disrupted the world and changed the course of medical history. Clinics were under lockdown and supplies of critical drugs such as biologics and meladinine were delayed. The prolonged impact of disease has taken its toll on patients, their careers, medical staff, research and medical education. Shortly after the first landmark studies of COVID-19 vaccine trial data were made known, global mass vaccination programs were underway. Vaccine technology has expanded beyond messenger RNA (mRNA) to include non-replicating viral vectors, inactivated virus, and protein subunits. Cutaneous manifestations of vaccine reactions, including non-mRNA and their morphological patterns, indications and contraindications, vaccine global access, equity, allocation of booster doses, emerging COVID variants and subvariants, waning vaccine and treatment efficacy are the issues that begged to be explored. New oral therapies are available for treatment of COVID-19 but they bring with them drug-drug interactions and potential side effects.This book is a compilation of a concerted effort by dermatologists across the globe to join hands against COVID-19. Each chapter has been written by experts in the field, with first-hand experience and synthesized literature to offer the most up-to-date coverage in the fast-paced, changing landscape of COVID-19 in dermatology. COVID-19 in Dermatology is a valuable resource for dermatologists, dermatology residents and medical students, and general practitioners.